Evidence map›Paper›PMID 25612115›Full record

ArticleCells2015

ELISPOTs Produced by CD8 and CD4 Cells Follow Log Normal Size Distribution Permitting Objective Counting.

Alexey Y Karulin, Kinga Karacsony, Wenji Zhang, Oleg S Targoni, Ioana Moldovan, Marcus Dittrich, Srividya Sundararaman, Paul V Lehmann

Abstract read
In one paragraph

Article in Cells, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Unbiased, High-Throughput Identification of T Cell Epitopes by ELISPOT.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexey Y KarulinCellular Technology Ltd., 20521 Chagrin Blvd. Shaker Heights, OH 44122, USA. ayk@immunospot.com.
Kinga KaracsonyCellular Technology Ltd., 20521 Chagrin Blvd. Shaker Heights, OH 44122, USA. kinga.karacson@immunospot.com.
Wenji ZhangCellular Technology Ltd., 20521 Chagrin Blvd. Shaker Heights, OH 44122, USA. wenji.zhang@immunospot.com.
Oleg S TargoniCellular Technology Ltd., 20521 Chagrin Blvd. Shaker Heights, OH 44122, USA. oleg.targoni@immunospot.com.
Ioana MoldovanCellular Technology Ltd., 20521 Chagrin Blvd. Shaker Heights, OH 44122, USA. ioana.moldovan@immunospot.com.
Marcus DittrichPh.D., Biocenter, University of Wuerzburg, Am Hubland, 97074 Würzburg, Germany. marcus.dittrich@biozentrum.uni-wuerzburg.de.
Srividya SundararamanCellular Technology Ltd., 20521 Chagrin Blvd. Shaker Heights, OH 44122, USA. srividya.sundararaman@immunospot.com.
Paul V LehmannCellular Technology Ltd., 20521 Chagrin Blvd. Shaker Heights, OH 44122, USA. pvl@immunospot.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Each positive well in ELISPOT assays contains spots of variable sizes that can range from tens of micrometers up to a millimeter in diameter. Therefore, when it comes to counting these spots the decision on setting the lower and the upper spot size thresholds to discriminate between non-specific background noise, spots produced by individual T cells, and spots formed by T cell clusters is critical. If the spot sizes follow a known statistical distribution, precise predictions on minimal and maximal spot sizes, belonging to a given T cell population, can be made. We studied the size distributional properties of IFN-γ, IL-2, IL-4, IL-5 and IL-17 spots elicited in ELISPOT assays with PBMC from 172 healthy donors, upon stimulation with 32 individual viral peptides representing defined HLA Class I-restricted epitopes for CD8 cells, and with protein antigens of CMV and EBV activating CD4 cells. A total of 334 CD8 and 80 CD4 positive T cell responses were analyzed. In 99.7% of the test cases, spot size distributions followed Log Normal function. These data formally demonstrate that it is possible to establish objective, statistically validated parameters for counting T cell ELISPOTs.

Identifiers

PMID25612115
PMCPMC4381209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.